Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Modulation of phagocytosis and intracellular bactericidal activity of polymorphonuclear and mononuclear cells by cationic proteins from human granulocytes: Alternative pathway of phagocytic enhancement


Cationic lysosomal proteins from human polymorphonuclears (PMN) were isolated by column chromatography and divided into five fractions. On acrylamide gel electrophoresis, fraction I had four bands slower than lysozyme (LZM) mobility; fraction II had five or six bands slower than LZM; fraction III had at least seven bands slower and two bands faster than LZM; fraction IV contained LZM, two bands faster and a few faint bands slower than LZM; fraction V was composed of almost pure LZM. Partial characterization of the fractions showed presence of neutral protease in fractions I-IV, chymotrypsin in fraction III, lysozyme in fractions IV and V, and phospholipase A2 mainly in fractions II and III. Modulatory activity of fractions I-V were tested at concentrations up to 50 μg/ml. Enhancement of phagocytosis ofStaphylococcus aureus was observed by fractions I, IV, and V, whereas phagocytic index was enhanced by all but the fraction II. Intracellular bactericidal activity (ICBA) was markedly enhanced by fractions I, II, and V. Addition of DNA or cytochalasine B inhibited or abolished phagocytosis-enhancing activity of cationic fractions. Their influence on ICBA was much less pronounced. Fraction III enhanced phagocytic index and phagocytosis ofE. colt, whereas fractions I and II enhanced intracellular bactericidal activity against this bacteria. Enhancement of phagocytic activity of monocytes has also been observed. The data suggest that some cationic lysosomal fractions from human PMNs enhance phagocytosis and phagocytic index by human PMNs and monocytes and intracellular bactericidal activity of human PMNs. This alternative pathway of phagocytic enhancement is unrelated to the previously described enhancers of phagocytosis and may play a role in defense mechanisms against infection.

This is a preview of subscription content, log in to check access.


  1. 1.

    Wardlaw, A. C. 1962. The complement-dependent bacteriolytic activity of normal human serum. I. The effect of pH and ionic strength and the role of lysozyme.J. Exp. Med. 115:1231–1249.

  2. 2.

    Zeya, H. I., andJ. K. Spitznagel. 1966. Antimicrobial specificity of leukocyte lysosomal cationic proteins.Science 154:1049–1051

  3. 3.

    Welsh, I. R. H., andJ. K. Spitznagel, 1971. Distribution of iysosomal enzymes, cationic proteins and bactericidal substances in subcellular fractions of human polymorphonuclear leukocytes.Infect. Immun. 4:97–102.

  4. 4.

    Zeya, H. I., andJ. K. Spitznagel. 1966. Cationic proteins of polymorphuclear leukocyte lysosomes, I. Resolution of antibacterial and enzymatic activities.J. Bacteriol. 91:750–754.

  5. 5.

    Stossel, T. P. 1975. Phagocytosis: Recognition and ingestion.Semin. Hematol. 12:83–116.

  6. 6.

    Gordon, S., J. Todd, andZ. A. Cohn. 1974. In vitro synthesis and secretion of lysozyme by mononuclear phagocytes.J. Exp. Med. 139:1228–1248.

  7. 7.

    Ranadive, N. S., andC. G. Cochrane. 1968. Isolationand characterization of permeability factors from rabbit neutrophils.J. Exp. Med. 128:605–622.

  8. 8.

    Janoff, A., andB. W. Zweifach. 1964. Adhesion and emigration of leukocytes produced by cationic proteins of lysosomes.Science 144:1456–1458.

  9. 9.

    Janoff, A, andB. W. Zweifach. 1964. Production of inflammatory changes in the microcirculation by cationic proteins extracted from lysosomes.J. Exp. Med. 120:747–764.

  10. 10.

    Golub, E. S., andJ. K. Spitznagel. 1965. The role of lysosomes in hypersensitivity reactions: Tissue damage by polymorphonuclear neutrophil lysosomes.J. Immunol. 95:1060–1066.

  11. 11.

    Janoff, A. S. Schaefer, andJ. Scherer. 1965. Mediators of inflammation in leukocyte lysosomes. II. Mechanism of action of lysosomal cationic proteins upon vascular permeability in the rat.J. Exp. Med. 122:841–851.

  12. 12.

    Olsson, I., andP. Venge, 1974. Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukaemic myeloid cells.Blood 44:235–246.

  13. 13.

    Olsson, I., andP. Venge. 1972. Cationic proteins of human granulocytes. I. Isolation of the cationic proteins from the granules of leukaemic myeloid cells.Scand. J. Haematl. 9:204–214.

  14. 14.

    Zeya, H. I., andJ. K. Spitznagel. 1968. Arginine-rich proteins of polymorphonuclear leukocyte lysosomes. Antimicrobial specificity and biochemical heterogeneity.J. Exp. Med. 127:927–941.

  15. 15.

    Spitznagel, J. K., F. G. Dalldorf, M. S. Leffell, J. D. Folds, I. R. H. Welsh, M. H. Cooney, andL. E. Martin. 1974. Character of azurophil and specific granules purified from human polymorphonuclear leukocytes.Lab. Invest. 30:774–785.

  16. 16.

    Zeya, H. I., andJ. K. Spitznagel. 1966. Cationic proteins of polymorphonuclear leukocyte lysosomes. II. Composition, properties and mechanism of antibacterial action.J. Bacteriol. 91:755–762.

  17. 17.

    Zeya, H. I., andJ. K. Spitznagel. 1963. Antibacterial and enzymic basic proteins from leukocyte lysosomes: Separation and identification.Science 142:1085–1087.

  18. 18.

    Pruzanski, W., andS. Saito. 1978. The influence of natural and synthetic cationic substances on phagocytic activity of human polymorphonuclear cells. An alternative pathway of phagocytic enhancement.Exp. Cell Res. 117:1–13.

  19. 19.

    Ranadive, N. S., A. N. Sajnani, K. Alimurka, andH. Z. Movat. 1973. Release of basic proteins and lysosomal enzymes from neutrophil leukocytes of the rabbit.Int. Arch. Allergy 45:880–898.

  20. 20.

    Gordon, J., andF. C. Thompson. 1937. Artificial opsonization of bacteria.Br. J. Exp. Pathol 18:390–395.

  21. 21.

    Westwood, F. R., andE. Longstaff. 1976. Stimulation of cellular ingestion by basic proteins in vitro.Br. J. Cancer 33:392–399.

  22. 22.

    Falke, D., E. M. Lemmel, L. S. Richardson, andH. U. Wolf. 1975. Enhancement of phagocytosis by compound 48/80 and its influence upon Ca+ dependent ATP-ase.Arzneimittelforschung 25:1258–1261.

  23. 23.

    Devries, A., J. Salgo, Y. Matoth, A. Nevo, andE. Katchalski. 1955. Effect of basic polyamino acids on phagocytosis in vitro.Arch. Int. Pharmacody. 104:1–10.

  24. 24.

    Hallgren, R., andP. Venge. 1976. Cationic proteins of human granulocytes: Enhancement of phagocytosis of staphylococcus protein A-IgG complexes.Inflammation 1:237–246.

  25. 25.

    Gordon, L. I., S. D. Douglas, N. E. Kav, E. F. Osserman, H. S. Jacob. 1979. Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation.J. Clin. Invest. 64:226–232.

  26. 26.

    Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood.Scand. J. Clin. Lab. Invest. Suppl. 97.21:77.

  27. 27.

    Kaplow, L. S., andC. Ladd. 1965. Simplified myeloperoxidase stain using benzidine dihydrochloride.Blood 26:215–219.

  28. 28.

    Yam, L. T., C. Y. Li, andW. H. Crosby. 1971. Cytochemical identification of monocytes and granulocytes.Am. J. Clin. Pathol. 55:283–290.

  29. 29.

    Williams, C. A. 1968. Determination of nitrogen by Nessler reaction.In Methods in Immunology and Lmmunochemstry. C. A. Williams and M. W. Chase (ed). Vol. 2, Academic Press, New York. 266–270.

  30. 30.

    Fishman, W. M. 1963. Determination of β-glucuronidase.In Methods of Enzymatic Analysis. H. U. Bergmeyer, editor. Academic Press, New York. 869.

  31. 31.

    Starkey, P. M., andA. J. Barrett. 1976. Neutral proteinases of human spleen. Purification and criteria for homogeneity of elastases and cathepsin G.Biochem. J. 155:255–263.

  32. 32.

    Osserman, E. F., andD. P. Lawlor. 1966. Serum and urinary lysozyme (muramidase) in monocytic and myelomonocytic leukemia.J. Exp. Med. 124:921–951.

  33. 33.

    Pruzanski, W., andM. E. Platts. 1970. Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia.J. Clin. Invest. 49:1694–1708.

  34. 34.

    Worthington Manual. 1967. Peroxidase Worthington Chemical Corp. Freehold, New Jersey,

  35. 35.

    Christman, J. K., S. C. Silverstein, andG. Acs. 1977. Fibrin plate method.In Proteinases in Mammalian Cells and Tissues. A. J. Barrett, editior. North Holland, Amsterdam. 136.

  36. 36.

    Ranadive, N. S., andC. G. Cochrane, 1971. Mechanism of histamine release from rat mast cells by cationic proteins from neutrophil lysosomes.J. Immunol. 106:506–516.

  37. 37.

    Vadas, P., andJ. B. Hay. 1980. The release of phospholipase A2 from aggregated platelets and stimulated macrophages of sheep.Life Sci. 26:1721–1729.

  38. 38.

    Peterson, P. K., J. Verhoef, L. D. Sabath, andP. G. Quie. 1976. Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes.Infect. Immun. 14:496–501.

  39. 39.

    Zimmerman, H. J., andJ. B. Henry. 1969.In Clinical Diagnosis by Laboratory Methods. 14th ed. I. Davidsohn and J. B. Henry, editors. W. B. Saunders, Philadelphia. 725.

  40. 40.

    Tan, J. S., C. Watanakunakorn, andJ. P. Phair. 1971. A modified assay of netrophil function: Use of lysostaphin to differentiate defective phagocytosis from impaired intracellular killing.J. Lab. Clin. Med. 78:316–322.

  41. 41.

    Goldner, M., H. Farkas-Himsley, A. Kormendy, andM. Skinner. 1983. Bacterial phagocytosis monitored by fluorescence and extracellular quenching: Ingestion and intracellular killing.Lab. Med. 14:291–294.

  42. 42.

    Pruzanski, W., andK. Delmage. 1977, Cytotoxic and eytolytic activity of homogeneous cold agglutinins on peripheral blood monocytes.Clin. Immunol. Immunopaihol. 7:130–138.

  43. 43.

    Stossel, T. P. 1974. Phagocytosis.N. Engl. J. Med. 290:717–723.

  44. 44.

    Windhorst, D. B. 1970. Functional defects of neutrophiles.Adv. Inter. Med. 16:329–349.

  45. 45.

    Van Oss, C. J., C. F. Gillman, andR. J. Good. 1972. The influence of the shape of phagocytes on their adhesiveness.Immunol. Commun. 1:627–636.

  46. 46.

    Karnovsky, M. L. 1962. Metabolic basis of phagocytic activity.Physiol. Rev. 42:143–168.

  47. 47.

    Sbarra, A. J., A. A. Jacobs, R. R. Strauss, B. B. Paul, andG. W. Mitchell, Jr. 1971. The biochemical and antimicrobial activities of phagocytizing cells.Am. J. Clin. Nutr. 24:272–281.

  48. 48.

    Cohn, Z. A., andJ. G. Hirsch. 1960. The isolation and properties of the specific cytoplasmic granules of rabbit polymorphonuclear leucocytes.J. Exp. Med. 112:983–1004.

  49. 49.

    Weissmann, G., andP. Dukor. 1970. The role of lysosomes in immune responses.Adv. Immunol. 12:283–331.

  50. 50.

    Weissmann, G. R. B. Zurier, P. J. Spieler, and1. M. Goldstein. 1971. Mechanism of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles,J. Exp. Med. 134:149s-165s.

  51. 51.

    Clark, R. A., I. Olsson, andS. J. Klebanoff. 1976, Cytotoxicity for tumor cells of cationic proteins from human neutrophil granules.J. Cell. Biol. 70:719–723.

  52. 52.

    Baker, P. J., T. F. Lint, J. Siegel, M. W. Kies, andH. Gewurz. 1976. Potentiation of C5,6-initiated lysis by leukocyte cationic proteins, myelin basic proteins and lysine-rich histones.Immunology 30:467–473.

  53. 53.

    Saba, H. I., H. R. Roberts, andJ. C. Herion. 1967. The anticoagulant activity of lysosomal cationic proteins from polymorphonuclear leukocytes.J. Clin. Invest. 46:580–589.

  54. 54.

    Klebanoff, S. J. 1970. Myeloperoxidase: Contribution to the microbicidal activity of intact leukocytes.Science 169:1095–1097.

  55. 55.

    Modrzakowski, M. C., M. H. Cooney, L. E. Martin, andJ. K. Spitznagel. 1979. Bactericidal activity of fractionated granule contents from human polymorphonuclear leukocytes.Infect. Immun. 23:587–591.

  56. 56.

    Odeberg, H., andI. Olsson. 1975. Antibacterial activity of cationic proteins from human granulocytes.J. Clin. Invest. 56:1118–1124.

  57. 57.

    Venge, P., andI. Olsson. 1975. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.J. Immunol. 115:1505–1508.

  58. 58.

    Steigbigel. R. T., L. H. Lambert, Jr., andJ. S. Remington. 1974. Phagocytic and bactericidal properties of normal human monocytes.J. Clin. Invest. 53:131–142.

  59. 59.

    Lemarbre, P., J. Rinehart, N. Kay, E. Osserman, andH. S. Jacob. 1979. Lysozyme (LYZ) enhances monocyte-mediated tumoricidal activity; A potential beneficial amplifier in tumor immunity.Blood (Suppl 1)54:103a.

  60. 60.

    Tischendorf, F. W. G. Ledderose, W. Wilmanns, M. M. Tischendorf, andG. W. Tischendorf. 1973. Cationic leukocyte antigen in urine of patients with chronic myelocytic leukaemia.Nature 245:379–380.

Download references

Author information

Additional information

Supported by grants-in-aid from the Medical Reseach Council of Canada and the Wellesley Hospital Research Institute.

This study was presented in part at the 9th International RES Congress, Davos, Switzerland, 1982.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pruzanski, W., Ranadive, N.S. & Saito, S. Modulation of phagocytosis and intracellular bactericidal activity of polymorphonuclear and mononuclear cells by cationic proteins from human granulocytes: Alternative pathway of phagocytic enhancement. Inflammation 8, 445–457 (1984). https://doi.org/10.1007/BF00918219

Download citation


  • Lysozyme
  • Alternative Pathway
  • Cytochalasine
  • Chymotrypsin
  • Phagocytic Activity